RadNet Inc (RDNT) Stock Analysis — PE Ratio, PS Ratio, Intrinsic Value & 2030 Price Target
RadNet Inc stock (RDNT) is currently trading at $59.87. RadNet Inc PS ratio (Price-to-Sales) is 2.28. Analyst consensus price target for RDNT is $92.38. WallStSmart rates RDNT as Underperform.
- RDNT PE ratio analysis and historical PE chart
- RDNT PS ratio (Price-to-Sales) history and trend
- RDNT intrinsic value — DCF, Graham Number, EPV models
- RDNT stock price prediction 2025 2026 2027 2028 2029 2030
- RDNT fair value vs current price
- RDNT insider transactions and insider buying
- Is RDNT undervalued or overvalued?
- RadNet Inc financial analysis — revenue, earnings, cash flow
- RDNT Piotroski F-Score and Altman Z-Score
- RDNT analyst price target and Smart Rating
RadNet Inc
📊 No data available
Try selecting a different time range
Smart Analysis
RadNet Inc (RDNT) · 10 metrics scored
Smart Score
Category Performance
WallStSmart pulls financial metrics like revenue growth, profit margins, and valuation ratios and scores each one from 0 to 10 based on how strong or weak it is. Those 10 scores are grouped into 4 categories: Growth, Profitability, Valuation, and Quality — which form the 4 axes of the spider chart you see. The categories are then combined into a final score out of 100, but not equally. Growth and Profitability together count for 60% of the total, because a fast-growing profitable business matters more than just a cheap one. That final number maps to a rating (Strong Buy, Buy, Hold, Avoid) and a letter grade, giving you one clear Stock Rating.
Investment Thesis
Strong fundamentals in peg ratio, eps growth, institutional own.. Concerns around return on equity and operating margin. Fundamentals are solid but monitor weak areas for improvement.
RadNet Inc (RDNT) Key Strengths (4)
Growing significantly faster than its price suggests
Earnings per share surging 75.00% year-over-year
99.97% of shares held by major funds and institutions
Mid-cap company balancing growth potential with stability
Supporting Valuation Data
RadNet Inc (RDNT) Areas to Watch (6)
Company is losing money with a negative profit margin
Very low returns on shareholder equity
Very thin margins with limited operational efficiency
Premium pricing at 4.4x book value
Revenue is fairly priced at 2.28x sales
Solid revenue growth at 14.80% per year
Supporting Valuation Data
RadNet Inc (RDNT) Detailed Analysis Report
Overall Assessment
This company scores 54/100 in our Smart Analysis, earning a C- grade. Out of 10 metrics analyzed, 4 register as strengths (avg 9.3/10) while 6 fall into concern territory (avg 3.2/10). The category breakdown reveals uneven performance, with some areas requiring attention.
The Bull Case
The strongest argument centers on PEG Ratio, EPS Growth, Institutional Own.. Valuation metrics including PEG Ratio (0.96) suggest the stock is attractively priced. Growth metrics are encouraging with EPS Growth at 75.00%.
The Bear Case
The primary concerns are Profit Margin, Return on Equity, Operating Margin. Some valuation metrics including Price/Sales (2.28), Price/Book (4.38) suggest expensive pricing. Growth concerns include Revenue Growth at 14.80%, which may limit upside. Profitability pressure is visible in Return on Equity at 1.37%, Operating Margin at 6.83%, Profit Margin at -0.91%.
Key Dynamics to Monitor
Three factors to monitor going forward. First, whether Profit Margin improves, as this is the primary drag on the overall score. Second, margin trajectory, with Return on Equity at 1.37% needing improvement to support the investment thesis. Third, growth sustainability, with Revenue Growth at 14.80% needing to reaccelerate.
Risk Considerations
Based on the metric profile, this is a moderate-to-high risk investment. There are more areas of concern than strength, warranting a more conservative position size. Investors should size positions according to their risk tolerance and maintain diversification.
Bottom Line
Mixed fundamentals with both positives (PEG Ratio, EPS Growth) and negatives (Profit Margin, Return on Equity). A cautious approach is warranted. Monitor for improvement in weak areas before increasing conviction.
Disclaimer: Smart Analysis is a scoring system developed by WallStSmart Team. Scores update daily using multi-model valuation framework. Always conduct your own research and consult with financial advisors before making investment decisions.
RDNT Price-to-Sales(PS) Ratio Chart
Historical valuation based on market cap ÷ trailing 12-month revenue
RDNT's Price-to-Sales ratio of 2.28x trades 142% above its historical average of 0.94x (88th percentile), historically expensive. The current valuation is 52% below its historical high of 4.77x set in Dec 2007, and 1323% above its historical low of 0.16x in Jan 2006. Over the past 12 months, the PS ratio has compressed from ~2.7x as trailing revenue scaled faster than the stock price.
Compare RDNT with Competitors
Top DIAGNOSTICS & RESEARCH stocks by market cap
Compare any two stocks →WallStSmart Analysis Synopsis
Data-driven financial summary for RadNet Inc (RDNT) · HEALTHCARE › DIAGNOSTICS & RESEARCH
The Big Picture
RadNet Inc is in a turnaround phase, with management focused on restoring profitability. Revenue reached 2.0B with 15% growth year-over-year. The company is currently unprofitable, posting a -91.0% profit margin.
Key Findings
ROE of 137.0% means the company generates strong returns on shareholder equity. Above 20% is considered top-tier.
The company is unprofitable with a -91.0% profit margin. The path to breakeven will be the key catalyst.
Free cash flow is -231M, meaning the company is burning cash. This may be acceptable for high-growth companies investing heavily.
What to Watch Next
Sector dynamics: monitor DIAGNOSTICS & RESEARCH industry trends, competitive moves, and regulatory changes that could impact RadNet Inc.
Bottom Line
RadNet Inc is in turnaround mode. The path to profitability remains the critical question. Speculative investors may see opportunity in the recovery story, but conservative investors should wait for consistent positive earnings before committing capital.
This synopsis is generated from publicly available financial data. It is not financial advice. Always conduct your own research and consult a qualified financial advisor before making investment decisions.
Insider Transactions
Loading insider activity...
About RadNet Inc(RDNT)
NASDAQ
HEALTHCARE
DIAGNOSTICS & RESEARCH
USA
RadNet, Inc., provides outpatient imaging services in the United States. The company is headquartered in Los Angeles, California.